STAT PROFILE recallZ-0207-2024 · Nova Biomedical Corporation · initiated Sep 18, 2023
Open, Classified
Is my device affected?
- Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
- If yours is listed, follow the instructions from Nova Biomedical Corporation or your healthcare provider. The company's action is summarized under what the company is doing.
- Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.
Where to find your model and lot numbers · What recall classes and statuses mean
Why it was recalled
Potential risk of reporting erroneous creatinine patient results associated with the initial start-up of a new BUN/Creatinine Sensor Cartridge. The potential risk is within the first 2-4 hours after cartridge installation that may not be identified by traditional Quality Control practices.
FDA root cause category: Process design
What the company is doing
Nova Biomedical Customer Success Managers starting 9/18/23 contacted consignees directly via telephone, to review the bulletin with the consignee DRP, verify an email to send the bulletin to them, and then immediately forward the bulletin to them so they can share within their own healthcare facility. Letter states the reason for recall, health risk and action to take: Nova Biomedical recommends that your healthcare facility take one of the following risk mitigation steps after a BUN/Creatinine Sensor Cartridge replacement to reduce the possibility of this issue occurring in your facility until your analyzers have received a software update. " If your analyzer tests patient samples frequently, initiate a manual analyzer calibration every 30 minutes within the first 2 hours, and then every hour for the next 2 hours after cartridge replacement. " If your analyzer tests patient samples infrequently, within the first 4 hours after cartridge replacement, initiate a manual analyzer calibration prior to performing a patient test. Until your Prime Plus analyzer(s) software is updated, if your healthcare facility experiences an erroneous creatinine result or adverse event after a new sensor cartridge installation, Nova encourages you to contact Nova Biomedical or your authorized distributor to properly document the incident. For adverse event(s), Nova encourages you to report the details using the MedWatch Online Voluntary Reporting Form, MedWatch Online Voluntary Reporting Form (fda.gov). INTERNAL HEALTHCARE FACILITY COMMUNICATION: This Field Correction Notice should be distributed to all those within your organization who need to be aware of this issue. Please notify other parties affiliated with your organization, which are affected by this notice. Please maintain awareness of this notice until the issue has been corrected with a scheduled software update. If you have any questions on the contents of this notice, would like to discuss other risk mitigation options
Recall details
- Recall number
- Z-0207-2024
- Status
- Open, Classified
- Initiated by the company
- Sep 18, 2023
- Posted by the FDA
- Nov 1, 2023
- Recalling firm
- Nova Biomedical Corporation
- Quantity
- 1779 units: 438 US; 1341 OUS
- Product code
- JGS
- FDA submissions
- K200403
- Distribution
- Nationwide Foreign: Country Algeria Australia Austria Bangladesh Benin Bolivia Brazil Canada Chile China Colombia Croatia CYPRUS Czech Republic Ecuador Egypt El Salvador Finland France Germany Greece Guatemala India Indonesia Ireland Israel Italy Japan JORDAN Kazakhstan Kenya Kurdistan, Iraq Kuwait Malaysia Malta Mexico Moldova Morocco Nepal Netherlands New Zealand Oman Pakistan Palestine Paraguay Paraquay Peru Philippines Poland Puerto Rico Qatar Republic of Panama Romania Russia Rwanda Saudi Arabia Serbia Slovenia South Africa South Korea Spain Sri Lanka Sudan Sweden Switzerland Syria Thailand Trinidad Trinidad,W.I. Tunisia UK Ukraine United Arab Emerites Uruguay Vietnam
Product description
Nova Biomedical Prime Plus Analyzer -Intended to measure certain gases in blood, serum, plasma or pH of blood, serum, and plasma. (1) PN 57400 Stat Profile Prime Plus Analyzer (2) PN 59508 Stat Profile Prime Plus Analyzer, Remanufactured
Code information (models, lots, serial numbers)
UDI-DI: (1) 00385480574006 (2) 00385480595087 All software versions (V1.17.1123.0 and V3.2.1123.0)
Devices named in this recall
2 devices in the FDA device registry whose identifier appears in the recall's code information.
- Stat Profile Prime PlusNova Biomedical Corporation · Electrode measurement, blood-gases (pco2, po2) and blood ph1 recall1 death50 reports
- Stat Profile Prime PlusNova Biomedical Corporation · Electrode measurement, blood-gases (pco2, po2) and blood ph1 recall0 reports
Product lines
Sources and updates
- Recall record: FDA Medical Device Recalls, file dated Oct 16, 2026 · View the FDA recall notice ↗
- Devices: FDA GUDID, file dated Oct 13, 2026. Devices are linked when their identifier (with a valid check digit) appears in the recall's code information.
- Page last rebuilt: Oct 16, 2026. Text above is shown as published by the FDA.
How recalls are matched to devices · Editorial policy · Report an error on this page